Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor".

Source:http://linkedlifedata.com/resource/pubmed/id/10897169

Download in:

View as

General Info

PMID
10897169